A clinical trial to study the effects of the drug metformin as a cream for patients with melasma
Phase 3
- Conditions
- Health Condition 1: L811- Chloasma
- Registration Number
- CTRI/2024/07/070444
- Lead Sponsor
- Anu Sarah Philip
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ADULT MALES OR FEMALES WITH A CLINICAL DIAGNOSIS OF MELASMA
Exclusion Criteria
Age less than 18 years or more than 80 years.
Pregnant.
Lactating.
Patients with a history of photosensitivity disorders.
Patients on medications known to cause hyperpigmentation or photosensitivity.
Patients on immunosuppressants .
Patients with facial pigmentation caused by conditions other than melasma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method